YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dishman Pharma
Dishman Pharma
BSE: 532526NSE: DPC02ISIN: INE353G01020

17th-Jan-2012 08:52Source: BSE

Dishman Pharma - Acquisition of Creapharm Parenterals

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that Company's Wholly Owned Subsidiary company, namely Carbogen Amcis AG., Switzerland has acquired Creapharm Parenterals, a subsidiary of France based Greapharm Group.

Creapharm Parenterals is a contract development and manufacturing organization specializing in liquid, semi-solid and injectable aseptic dosage forms. As part of this acquisition, Creapharm Parenterals has changed its name to CARBOGEN AMCIS SAS.

The acquisition will extend CARBOGEN AMCIS' comprehensive range of development and manufacturing services by adding complementary formulation, lyophilization services and sterile GMP capabilities for the fast supply of drug products, including highly potents, for preclinical studies and clinical trials (Phase I, II & III).

More Announcements on:

20th-Sep-2017 12:21Source: BSE

Dishman Pharma - Updates

15th-Sep-2017 17:07Source: BSE

Dishman Pharma - Updates

5th-Sep-2017 15:51Source: BSE

Dishman Pharma - Updates

22nd-Aug-2017 12:52Source: BSE

Dishman Pharma - Fixes Book Closure for AGM

11th-Aug-2017 16:47Source: BSE

Dishman Pharma - Investor Presentation

1 2 3 4 5 Next >>
Follow us on
Available On